Literature DB >> 19630604

Clonidine in child and adolescent psychiatry.

R D Hunt, L Capper, P O'Connell.   

Abstract

Entities:  

Year:  1990        PMID: 19630604     DOI: 10.1089/cap.1990.1.87

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  13 in total

Review 1.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

2.  A multidimensional approach to medication selection in the treatment of children and adolescents with ADHD.

Authors:  Atilla Turgay
Journal:  Psychiatry (Edgmont)       Date:  2007-08

Review 3.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

4.  Clonidine extended release in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Mathew Nguyen; Kimberly A White; Regina Bussing
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

5.  Switching from Clonidine Immediate-Release to Guanfacine Extended-Release.

Authors:  Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2020-05-01

Review 6.  Effective treatment for mental disorders in children and adolescents.

Authors:  B J Burns; K Hoagwood; P J Mrazek
Journal:  Clin Child Fam Psychol Rev       Date:  1999-12

Review 7.  A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder.

Authors:  Leslie Briars; Timothy Todd
Journal:  J Pediatr Pharmacol Ther       Date:  2016 May-Jun

Review 8.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

9.  Noradrenergic α2A-receptor stimulation in the ventral hippocampus reduces impulsive decision-making.

Authors:  Andrew R Abela; Yogita Chudasama
Journal:  Psychopharmacology (Berl)       Date:  2013-09-06       Impact factor: 4.530

Review 10.  Psychopharmacological treatment of oppositional defiant disorder.

Authors:  Atilla Turgay
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.